Bulletin
Investor Alert

New York Markets Close in:

Celyad S.A. ADR

NAS: CYAD

GO
/marketstate/country/us

Market open

/zigman2/quotes/201188973/composite

$

9.12

Change

-0.05 -0.53%

Volume

Volume 3,739

Sep 25, 2020, 11:15 a.m.

Quotes are delayed by 20 min

/zigman2/quotes/201188973/composite

Previous close

$ 9.17

$ 9.12

Change

-0.05 -0.53%

Day low

Day high

$9.12

$9.16

Open
Open: 9.16

52 week low

52 week high

$4.10

$13.01

Open

Market cap

$129.67M

Average volume

7,451

P/E ratio

N/A

Rev. per Employee

$42,641

EPS

-2.36

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/cyad

MarketWatch News on CYAD

  1. Celyad started at buy with $49 stock price target at SunTrust RH

    7:55 a.m. May 31, 2018

    - Tomi Kilgore

  2. Celyad downgraded to neutral from buy at UBS

    9:49 a.m. July 5, 2016

    - Tomi Kilgore

  3. Celyad stock price target cut to $27 from $79 at UBS

    9:50 a.m. July 5, 2016

    - Tomi Kilgore

  4. Biogen’s Billion-Dollar Bet on Gene Therapy

    10:55 a.m. July 7, 2015

    - Barron's Online

Analyst Ratings

/news/nonmarketwatch/company/us/cyad

Other News on CYAD

  1. Celyad Oncology inks $25M stock sales deal

    6:12 a.m. Sept. 14, 2020

    - Seeking Alpha

  2. TSLA, HBI among premarket gainers

    8:22 a.m. July 14, 2020

    - Seeking Alpha

  3. Biotech IPO Nkarta triples in debut

    12:45 p.m. July 10, 2020

    - Seeking Alpha

  4. IPO Update: Nkarta Proposes Terms For $150 Million IPO

    12:05 p.m. July 5, 2020

    - Seeking Alpha

  5. Celyad up 9% on positive data on non-gene edited CAR T therapy

    11:16 a.m. June 1, 2020

    - Seeking Alpha

  6. Spotlight On Tech Momo, Bitcoin Halving And 13Fs

    8:58 a.m. May 9, 2020

    - Seeking Alpha

  7. Top Ranked Momentum Stocks to Buy for April 20th

    9:06 a.m. April 20, 2020

    - Zacks.com

  8. Stocks To Watch: OPEC Goes Virtual

    9:04 a.m. April 4, 2020

    - Seeking Alpha

  9. What Makes Celyad SA (CYAD) a New Buy Stock

    12:00 p.m. March 31, 2020

    - Zacks.com

  10. Celyad: Early Stage CAR-T Company With A Different Approach

    10:55 a.m. March 11, 2020

    - Seeking Alpha

  11. Celyad: Assessing This CAR-T Concern

    7:20 p.m. Feb. 4, 2020

    - Seeking Alpha

  12. Celyad updates on NKG2D-based CAR-T therapy

    9:19 a.m. Dec. 10, 2019

    - Seeking Alpha

  13. AMTD, SCHW, CGC among premarket gainers

    10:25 a.m. Nov. 21, 2019

    - Seeking Alpha

  14. Loading more headlines...
/news/pressrelease/company/us/cyad

Press Releases on CYAD

  1. Celyad Oncology Establishes At-the-Market Facility

    6:48 a.m. Sept. 14, 2020

    - GlobeNewswire

  2. Celyad Oncology Establishes At-the-Market Facility

    1:00 a.m. Sept. 14, 2020

    - GlobeNewswire

  3. Celyad Oncology Announces September 2020 Conference Schedule

    1:00 a.m. Aug. 26, 2020

    - GlobeNewswire

  4. Celyad Oncology Announces September 2020 Conference Schedule

    1:00 a.m. Aug. 26, 2020

    - GlobeNewswire

  5. By 2025 Stem Cell Therapy Market Revenue to Reach USD 15 Billion

    12:17 a.m. Aug. 17, 2020

    - Market Insight Reports

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.